Pu-Yuan Xing, Ligang Xing, Ying Cheng, Yongzhong Luo, Zhengguo Li, Qin Xin, Chengqin Li, Xiu Gui Chen, Yusheng Wu, Yuankai Shi. "A phase II study of asandeutertinib (TY-9591) in advanced NSCLC patients with EGFR-positive mutations and brain metastases.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2004